Solan, August 9
Dr. Lalit Sharma, Associate Professor from the Faculty of Pharmaceutical Sciences at Shoolini University, attended 2023 International Alzheimer’s Association Conference (AAIC) which was held in Amsterdam.
The distinguished Alzheimer’s Association bestowed fellowship upon Dr. Sharma and provided him an opportunity to participate and present his groundbreaking research to audience of over 10,000 delegates from around the world. His visionary work, centered on novel compounds that target the aggregation of amyloid beta, a hallmark of Alzheimer’s disease, captivated the gathering and positioned him as a pioneering force in the field.
Dr. Sharma’s presentation showcased the results of his groundbreaking research, which revolves around the development of innovative compounds designed to halt the progression of Alzheimer’s disease by inhibiting amyloid beta aggregation. This advancement holds immense promise for the quest to find effective treatments for this devastating neurodegenerative ailment.
At the AAIC, Dr. Lalit’s contributions were a major highlight amidst a plethora of cutting-edge advancements in Alzheimer’s therapeutics.
